CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 59 enrolled
Drug / intervention
HWD1000device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02122549
NCT02122549N/ACompleted

Hospital Wearable Defibrillator Inpatient Study

Zoll Medical Corporation·interventional·Posted Apr 24, 2014·Updated May 31, 2017

In Brief

A clinical study evaluating HWD1000 for In-Hospital Cardiac Arrest. Completed, enrolled 59 participants across 8 sites.

Detailed Summary

This study will obtain device-human interaction evaluations for the HWD1000 within the controlled environment of the hospital as well as establish that the safety profile is similar to outpatient wearable cardioverter-defibrillators use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 24, 2014
Enrollment StartApr 1, 2014
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.2 years ago

Interventions

HWD1000device

Wearable cardioverter-defibrillator designed for inpatient use